Eli Lilly reports strong Q2 2025 growth, driven by Mounjaro & Zepbound. Highlights include increased guidance, pipeline updates, and key clinical milestones.

As the Official Beverage Partner of L&T Metro Rail (Hyderabad) Ltd (L&TMRHL), the company now has the Exclusive Selling ...